Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:compared |
gptkb:bevacizumab
gptkb:ranibizumab |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:endDate |
2013
|
| gptkbp:field |
ophthalmology
|
| gptkbp:focus |
treatment efficacy
treatment safety |
| gptkbp:fullName |
gptkb:Comparison_of_Age-related_macular_degeneration_Treatments_Trials
|
| https://www.w3.org/2000/01/rdf-schema#label |
CATT
|
| gptkbp:principalInvestigator |
gptkb:Daniel_F._Martin
|
| gptkbp:publishedIn |
gptkb:New_England_Journal_of_Medicine
|
| gptkbp:sponsor |
gptkb:National_Eye_Institute
|
| gptkbp:startYear |
2008
|
| gptkbp:studies |
age-related macular degeneration
|
| gptkbp:bfsParent |
gptkb:Catapult_Communications_Corporation
|
| gptkbp:bfsLayer |
6
|